Capitainer Secures SEK 21 million to Boost Production and Establish Its Presence on the American Market
Swedish medtech company Capitainer secures about SEK 21 million in funding to boost its production capabilities and broaden its sales efforts across Europe and the U.S. The investment, led by Sciety and the Sciety Venture Partners network, underscores the strong confidence and growing interest in Capitainer's breakthrough technology and potential to advance the healthcare sector.Capitainer offers an innovative self-sampling platform for fingertip blood collection, designed to streamline and enhance the accuracy of the collection process—critical for ensuring dependable test results. By